To reduce the serious risk of spreading infections and ensure insulin pens and other injectable diabetes medicines are being used appropriately, FDA is mandating these injectable devices display the warning label “For single patient use only.” Multi-dose pen devices are designed to be administered to a single patient multiple times, not multiple patients. The sharing of these devices amongst multiple patients significantly increases the risk of infection spreading. Over the last seven years, thousands of patients have potentially been victims to infections transmitted through the sharing of these multi-dose injectable devices. The “For single patient use only” warning label is intended to greatly reduce the risk of spreading infection amongst patients.
Click here to read FDA’s full safety announcement.